ERDOSTYNE 300mg Capsule 10's
Netmeds First Membership
Quick Links
Introduction About ERDOSTYNE 300MG CAPSULE
ERDOSTYNE 300MG CAPSULE is used to manage the symptoms associated with short, severe episodes of worsening of chronic bronchitis. It contains Erdosteine which belongs to the group of medicines known as Mucolytic agents which acts on the phlegm (mucus) in the respiratory tract or airways.
ERDOSTYNE 300MG CAPSULE is not recommended for use in patients having severe liver problems, kidney impairment or stomach ulcer. ERDOSTYNE 300MG CAPSULE is not recommended for use in pregnant and breastfeeding women. Consult your doctor before taking the medicine.
ERDOSTYNE 300MG CAPSULE is not recommended for use in children and adolescents below 18 years of age. The most common side effect of taking ERDOSTYNE 300MG CAPSULE is epigastric pain. Consult your doctor if the above side effects persists for a longer duration.
Uses Of ERDOSTYNE 300MG CAPSULE
- It is used to manage the symptoms associated with short, severe episodes of worsening of chronic bronchitis
How ERDOSTYNE 300MG CAPSULE Works
ERDOSTYNE 300MG CAPSULE contains Erdosteine which is a mucolytic drug. It is a prodrug and it becomes active after metabolism which acts by reducing the viscosity of mucus. In addition, it has a significant antioxidant action and it inhibits bacterial adhesion to epithelial cells.
How to use ERDOSTYNE 300MG CAPSULE
Take ERDOSTYNE 300MG CAPSULE as advised by your physician. Swallow this medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of ERDOSTYNE 300MG CAPSULE for you depending upon your age, body weight and disease condition.
Side Effects Of ERDOSTYNE 300MG CAPSULE
Common
- epigastric pain
Uncommon
- headache
- cold and difficulty in breathing and taste
- alterations, nausea, vomiting
- diarrhoea
- swelling of the blood vessels below the skin, mucosal tissues due to allergic reaction (angioedema)
- itching and redness of the skin
- oedema
- eczema
How To Manage Side Effects
Bloating
Apply a heating pad on your stomach for 15 to 20 minutes. Avoid lying flat. Try to rest and relax and have smaller and frequent meals. If the symptom does not improve, consult your doctor for advice.
Warning & Precautions
Pregnancy
ContraindicatedERDOSTYNE 300MG CAPSULE is not recommended for use in pregnant women. Consult your doctor before taking ERDOSTYNE 300MG CAPSULE.
Breastfeeding
ContraindicatedERDOSTYNE 300MG CAPSULE is not recommended for use in breastfeeding women. Consult your doctor for advice before taking ERDOSTYNE 300MG CAPSULE.
Driving and Using Machines
Use with CautionERDOSTYNE 300MG CAPSULE has minor or negligible influence on the ability to drive and use machines. Consult your doctor before taking ERDOSTYNE 300MG CAPSULE.
Kidney
ContraindicatedERDOSTYNE 300MG CAPSULE is not recommended for use in patients with severe decreased kidney function. Consult your doctor before taking ERDOSTYNE 300MG CAPSULE.
Liver
Consult your doctorERDOSTYNE 300MG CAPSULE is not recommended for use in patients with severe liver failure. It should be used with caution if you have mild liver failure. Consult your doctor before taking ERDOSTYNE 300MG CAPSULE.
Allergy
ContraindicatedDo not take ERDOSTYNE 300MG CAPSULE if you are allergic to Erdosteine or any other ingredients of this medicine.
Use In Pediatrics
ContraindicatedERDOSTYNE 300MG CAPSULE is not recommended for use in children and adolescents (below 18 years of age). Consult your child’s doctor for advice.
Others
ERDOSTYNE 300MG CAPSULE is not recommended for use if you have:
- stomach ulcer
Interactions
A. Drug-Drug interactions:
Before taking ERDOSTYNE 300MG CAPSULE, inform your doctor if you are taking any prescription, non-prescription or herbal supplements.
Overdosage:
If you or anyone else accidentally takes too much of ERDOSTYNE 300MG CAPSULE, consult your doctor immediately or visit the nearby hospital. The most common symptoms are sweating, vertigo and flushing.
Synopsis
| Drug | : | Erdosteine |
| Pharmacological Category | : | Mucolytic agents |
| Therapeutic Indication | : | Used to manage the symptoms associated with short, severe episodes of worsening of chronic bronchitis |
| Dosage Forms | : | Capsule |
More Information
Storage
- Keep ERDOSTYNE 300MG CAPSULE out of reach of children
- Store at room temperature
FAQs About ERDOSTYNE 300MG CAPSULE
Q: What precautions do I need to follow while taking ERDOSTYNE 300MG CAPSULE?
A: Patients taking ERDOSTYNE 300MG CAPSULE must inform their doctor about their pre-existing disease conditions like liver, kidney disease or stomach ulcer. Consult your doctor immediately if you experience any unusual symptoms after taking ERDOSTYNE 300MG CAPSULE.
Q: What happens if I stop taking ERDOSTYNE 300MG CAPSULE?
A: Do not stop taking ERDOSTYNE 300MG CAPSULE without talking to your doctor first. Consult your doctor for advice before taking the medicine.
Q: Is ERDOSTYNE 300MG CAPSULE safe to use in patients with kidney problems?
A: No. ERDOSTYNE 300MG CAPSULE is not recommended for use in patients with severe decreased kidney function. Consult your doctor before taking ERDOSTYNE 300MG CAPSULE.
Q: What is the main cause of chronic bronchitis?
A: Chronic bronchitis is typically caused by long-term exposure to irritants that harm the lungs and airways. Other inhaled irritants can also contribute to chronic bronchitis. Tobacco smoke, air pollution, and chemical fumes or dusts from the environment or workplace are examples.
Q: What diagnostic procedures are available for chronic bronchitis?
A: Chronic bronchitis is diagnosed using pulmonary function tests, arterial blood gas analysis, pulse oximetry, a chest X-ray, and CT scan.
References
1. NIPRO JMI Pharma Ltd. [Accessed on August 30th 2024] https://www.niprojmipharma.com/uploads/files/86157-erdostin_insert.pdf
2. Galen Limited. Edmond Pharma S.r.l. Electronic medicines compendium (EMC). [Revised on June 2019] [Accessed on August 30th 2024] https://www.medicines.org.uk/emc/files/pil.287.pdf
3. Edmond Pharma S.r.l. [Revised on June 2020] [Accessed on August 30th 2024] https://quest3plus.bpfk.gov.my/front-end/attachment/3051/pharma/515313/515313_20200630_130030_.pdf
4. Edmond Pharma S.r.l. [Revised on February 2021] [Accessed on August 30th 2024] https://www.hpra.ie/img/uploaded/swedocuments/34071039-fe52-4469-aba3-6855977ccb41.pdf
Author Details
